{"name":"Elysium Therapeutics, Inc.","slug":"elysium-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxONm1IZEZEaUh3dWZMNUdocWp1R3Fkc29TZFZsY25lZ3Uyb0R4LWZJa05VTUtncEJ0WjNERFR2VTVHNHN4YlZBVlV6VUpja1puX012UkZMSUo0OXBFQW5iYWl4NkxDdG5Lckt4VHBlSVB1UWZ1ZzV4VEJDdjQwTVluWHBsN3pwYjVsT0N0QnBmVm50Z3dh?oc=5","date":"2026-02-20","type":"pipeline","source":"Insightace Analytic","summary":"Anti-aging Therapeutics Market Size, Scope, Growth and Forecast to 2035 - Insightace Analytic","headline":"Anti-aging Therapeutics Market Size, Scope, Growth and Forecast to 2035","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxOWjQxV25nb3VnQWVFcFhDa2ROS3lJN1VDYUNadTFhaUpHRHU2UjBZNFB6UmIxd2ZhZm1meHVBYzlPeEsxNWFpclR1ZHhPeEtlS0JiSzdmbmRpMVQ3Q2FNa3JWdG0xTXdyVXNSVnV0QlVCQllKaDNaNE1SVERlOGlMZnRZNDRBcUZ1VENZYVY5YVhXRzJNTndjc0ZtSk5UdkhveDNHTFgyMEtENWExS0tqU25aWVRVS2o0UXB5ODF1OWtnaGVMSkY3MS11ZjdkdFdXWHdjNFFZRGNRQnFIN2FRdWN4OHQtNkJ5OXk2R3A2ZE85UFpuTk56SDQteUhSb3Z3VWpBQTIxMkJ3R0lUSEROSXJEQ2ZiXy1HMkhaSmpOVGQwTUpvTDBib1NEcG5OZUFLSmwxNGNn?oc=5","date":"2026-01-28","type":"pipeline","source":"PR Newswire","summary":"Elysium Therapeutics Raises $7.5 Million SAFE Round to Accelerate Development of Novel Rescue Therapy Designed to Specifically Combat Oral Fentanyl Overdose - PR Newswire","headline":"Elysium Therapeutics Raises $7.5 Million SAFE Round to Accelerate Development of Novel Rescue Therapy Designed to Specif","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxNV3RNNEVoRm9yN1RGd0Q4WmtGOUU5LU5tZXNjVS1ycGxVbGtKUlgxQVptUjNNR211UFFSdnpTS2RrUFA5SlFJVHBscERsbVBsaUJxWGQtNG02LTNYQ19Nb2ZldmR0WHVjNTNfMVNPaDVVZ3VBR25KUWtWTEtjUGlzbEZVWWt5cnlYLWw3Y1hWZDhKZzB6blBPbHFSUnlZTzdaRFpIVGxfbkVEaWRPak1DeGJWQmZBMUJQY1V4WmFLQzI0WHE5RzE0a1ZJODh1RDBFZHBrZ2lDLWg5R1RrUHRNR1YwU3d3bEJiTjFWZUVTQjhJTXl2ajBKeXo5bTN3UTRJZEUxOV9wM1YzNms?oc=5","date":"2025-08-20","type":"regulatory","source":"PR Newswire","summary":"Elysium Therapeutics Completes Pre-IND Meeting with FDA for First-Ever Technology Designed to Combat Oral Fentanyl Overdose - PR Newswire","headline":"Elysium Therapeutics Completes Pre-IND Meeting with FDA for First-Ever Technology Designed to Combat Oral Fentanyl Overd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQY1FLck1yTW5Xd2NsU2E3Tk9oeTUzbWFaRTNyLVZIU0doa0tuS0twZzd3MDVTcXdsNEhmbHdoYUc0SlFjQkVIb09TaXpHdDRacWdTSW05YVo5MmJxcTl6cmZFb0JMRGVRTWx4c2VGSy1fdkw3ZW1admpadDRDQWdHTXpSN24xMU5LN18yUWp3aDFlR1JDMTJPTmVn?oc=5","date":"2025-08-15","type":"pipeline","source":"BioWorld News","summary":"Elysium fields SOOPR overdose fix to fill opioid void - BioWorld News","headline":"Elysium fields SOOPR overdose fix to fill opioid void","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOVXZfR2ZTSnYyRGdQc3NEY2JlSDdzSG1yaEJlY3NsR1J6TU9HMHdBYXludkhqbkhaalRuWHE0VXFLVEZzaDg0WDA3SHMzRTBGOUozTG1XQTNXQnl6a2pRYm5nb0QwcmxMemNYYVl0RHF4b0lhYlN3aWJkeUZURWFvWmQwQ2pPb0NxM1lSMVBoNUVjQ05OSURmN3FBeXRud183cXk3TjZmQUpXemRZTzFjdHdSX2E?oc=5","date":"2017-11-24","type":"pipeline","source":"Bloomberg.com","summary":"Tangled Incentives Push Drugmakers Away From an Opioid Solution - Bloomberg.com","headline":"Tangled Incentives Push Drugmakers Away From an Opioid Solution","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}